Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far.

Mistry S, Ives N, Harding J, Fitzpatrick-Ellis K, Lipkin G, Kalra PA, Moss J, Wheatley K.

J Hum Hypertens. 2007 Jul;21(7):511-5. Epub 2007 Mar 22.

PMID:
17377602
2.

Effect of renal artery revascularization upon cardiac structure and function in atherosclerotic renal artery stenosis: cardiac magnetic resonance sub-study of the ASTRAL trial.

Ritchie J, Green D, Chrysochou T, Hegarty J, Handley K, Ives N, Wheatley K, Houston G, Wright J, Neyses L, Chalmers N, Mark P, Patel R, Moss J, Roditi G, Eadington D, Lukaschuk E, Cleland J, Kalra PA.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1006-1013. doi: 10.1093/ndt/gfw107.

PMID:
27257278
3.

Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial.

Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M, Kuntz R, Jamerson K, Reid D, Rosenfield K, Rundback J, D'Agostino R, Henrich W, Dworkin L.

Am Heart J. 2006 Jul;152(1):59-66.

PMID:
16824832
4.

Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL).

Herrmann SM, Saad A, Textor SC.

Nephrol Dial Transplant. 2015 Mar;30(3):366-75. doi: 10.1093/ndt/gfu067. Epub 2014 Apr 9. Review.

5.

Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.

Rocha-Singh K, Jaff MR, Rosenfield K; ASPIRE-2 Trial Investigators.

J Am Coll Cardiol. 2005 Sep 6;46(5):776-83.

6.

The management of renovascular disease: ASTRAL and beyond.

Cheung CM, Chrysochou C, Kalra PA.

Curr Opin Nephrol Hypertens. 2011 Jan;20(1):89-94. doi: 10.1097/MNH.0b013e328340ffe5. Review.

PMID:
21045682
7.

Extrarenal atherosclerotic disease blunts renal recovery in patients with renovascular hypertension.

Khangura KK, Eirin A, Kane GC, Misra S, Textor SC, Lerman A, Lerman LO.

J Hypertens. 2014 Jun;32(6):1300-6. doi: 10.1097/HJH.0000000000000160.

8.

Do patients undergoing renal revascularization outside of the ASTRAL trial show any benefit? Results of a single-centre observational study.

Valluri A, Severn A, Chakraverty S.

Nephrol Dial Transplant. 2012 Feb;27(2):734-8. doi: 10.1093/ndt/gfr356. Epub 2011 Sep 9.

PMID:
21765186
9.

The effect of revascularization of renal artery stenosis on renal perfusion in patients with atherosclerotic renovascular disease.

Koivuviita N, Liukko K, Kudomi N, Oikonen V, Tertti R, Manner I, Vahlberg T, Nuutila P, Metsärinne K.

Nephrol Dial Transplant. 2012 Oct;27(10):3843-8. doi: 10.1093/ndt/gfs301. Epub 2012 Jul 10.

PMID:
22785108
10.

Endovascular versus medical therapy for atherosclerotic renovascular disease.

Yu MS, Folt DA, Drummond CA, Haller ST, Cooper EL, Brewster P, Evans KL, Cooper CJ.

Curr Atheroscler Rep. 2014 Dec;16(12):459. doi: 10.1007/s11883-014-0459-4. Review.

11.

Atherosclerotic renal artery stenosis and renovascular hypertension: clinical diagnosis and indications for revascularization.

Kerut EK, Geraci SA, Falterman C, Hunter D, Hanawalt C, Giles TD.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):502-9. Review.

12.

Contemporary management of atherosclerotic renovascular disease.

Edwards MS, Corriere MA.

J Vasc Surg. 2009 Nov;50(5):1197-210. doi: 10.1016/j.jvs.2009.05.048. Epub 2009 Jul 12. Review.

13.

Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.

Urbieta-Caceres VH, Zhu XY, Jordan KL, Tang H, Textor K, Lerman A, Lerman LO.

Atherosclerosis. 2012 Apr;221(2):350-8. doi: 10.1016/j.atherosclerosis.2011.10.005. Epub 2011 Oct 12.

14.

Influence and critique of the ASTRAL and CORAL Trials.

Sarac TP.

Semin Vasc Surg. 2011 Sep;24(3):162-6. doi: 10.1053/j.semvascsurg.2011.11.001. Review.

PMID:
22153027
15.

Revascularization for atherosclerotic renal artery stenosis: another flawed son of the ASTRAL Study.

Calò LA, Caielli P, Maiolino G, Pessina AC, Rossi GP.

Hypertens Res. 2013 Jan;36(1):85-6. doi: 10.1038/hr.2012.148. Epub 2012 Sep 27. No abstract available.

PMID:
23013889
16.

[Renal arteries stenting. Indications, procedure, results].

Furkalo SN.

Klin Khir. 2007 Aug;(8):32-5. Russian.

PMID:
18318068
17.

Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).

Balzer KM, Pfeiffer T, Rossbach S, Voiculescu A, Mödder U, Godehardt E, Sandmann W.

J Vasc Surg. 2009 Mar;49(3):667-74; discussion 674-5. doi: 10.1016/j.jvs.2008.10.006. Epub 2009 Jan 9.

18.

High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization.

Ritchie J, Green D, Chrysochou C, Chalmers N, Foley RN, Kalra PA.

Am J Kidney Dis. 2014 Feb;63(2):186-97. doi: 10.1053/j.ajkd.2013.07.020. Epub 2013 Sep 26.

PMID:
24074824
19.
20.

Grand Rounds at the British Hypertension Society: renal artery stenosis.

Brady AJ, Mackenzie IS, Ritchie S, Brown MJ.

J Hum Hypertens. 2007 Sep;21(9):750-5. Epub 2007 Jul 12.

PMID:
17625589

Supplemental Content

Support Center